Exogenous application of the full-length amino-acid neuropeptide of α-MSH mediated neuroprotection and reduced tissue damage in experimental cerebral lesions like ischemic brain damage in models of focal and global cerebral ischemia or after spinal cord injury [25], [40]–[42]. Here, STAMBP is linked to Abnormal cerebral morphology.